Germany

Pharmtech & Ingredients

Not Confirmed

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule

Grade : Oral

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5

Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A

Dosage Form : Capsule

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A

Dosage Form : Capsule

Category : Controlled & Modified Release

Brand : EUDRAGIT® L 100

Applications : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5

Grade : Oral

Looking for METHACRYLIC ACID COPOLYMER TYPE A ? Find Controlled & Modified Release & other pharma excipients for Capsule dosage forms on PharmaCompass.

01